Pill Identification using a Mobile Phone App for Assessing Medication
  Adherence and Post-Market Drug Surveillance by Prokop, david et al.
 Pill Identification using a Mobile Phone App for Assessing Medication 
Adherence and Post-Market Drug Surveillance 
 
 
 
 
   by   David M. Prokop 
a,b
,     (Correspondence Author) 
 
         Joseph B. Babigumira 
c
,  
 
       Ashleigh Lewis 
d 
 
  
 
a
 PI, TruMedicines Ai, Sammamish, WA., United States  
b
 BSc. School of Health & Computer Science, University of Waterloo, Waterloo, ON, Canada 
c
 PI, Assoc Prof, Global Health, Adjunct Assoc Prof, Pharmacy, University of Washington, Seattle,WA,USA  
d
 REDCap Administrator, BA University of Washington, ITHS Medicine Research IT, Seattle, WA, USA 
 
 
  
 
Pill Identification using a Mobile Phone App for Assessing Medication 
Adherence and Post-Market Drug Surveillance 
 
   by   David M. Prokop 
a,b
, Joseph B. Babigumira 
c
, Ashleigh Lewis 
d
  
 
a
 PI, TruMedicines Ai, Sammamish, WA., United States  
b
 BSc. School of Health & Computer Science, University of Waterloo, Waterloo, ON, Canada 
c
 PI, Assoc Prof, Global Health, Adjunct Assoc Prof, Pharmacy, University of Washington, Seattle,WA,USA  
d
 REDCap Administrator, BA University of Washington, ITHS Medicine Research IT, Seattle, WA, USA 
 
ABSTRACT 
Objectives: Medication non-adherence is an important factor in clinical practice and research 
methodology. There have been many methods of measuring adherence yet no recognized 
standard for adherence.  Here we conduct a software study of the usefulness and efficacy of a 
mobile phone app to measure medication adherence using photographs taken by a phone app of 
medications and self-reported health measures. 
 
Method: A total of 34 participants were recruited to participate in the study. Out of these, 26 (76.5%) 
participants were able to complete study questionnaire while 8 (23.5%) were not able. Participants 
volunteered in a study of the efficacy of a mobile phone app for medication adherence and 
measurement of mood and health measures. Participants used their own android mobile phones 
and downloaded our phone application. Participants were instructed to take a photo of 1 harmless 
placebo pill (breath mints) a day for 2 weeks, and record their answers linked to a Research 
Electronic Data Capture (REDCap)[1] data collection server using MyCap[2] enabled phone 
application. Pill image and self-reported health measurements were recorded daily. Participants 
were paid for a stipend for participation. 
  
Results:  The participants were asked by the app ‘would help to keep track of your medication’, 
their response indicated 92.9% felt the app ‘would you use this app every day’ to improve their 
medication adherence. The subjects were also asked by the app if they ‘would photograph their 
pills on a daily basis’. Subject responses indicated 63% would use the app on a daily basis. By 
using the data collected, we determined that subjects who used the app on daily basis were more 
likely to adhere to the prescribed regimen.  
 
Conclusions:  Pill photographs are a useful measure of adherence, allowing more accurate time 
measures and more frequent adherence assessment. Given the ubiquity of mobile telephone use, 
and the relative ease of this adherence measurement method, we believe it is a useful and cost-
effective approach. However we feel the ‘manual’ nature of using the phone for taking a 
photograph of a pill has individual variability and an ‘automatic’ method is needed to reduce 
data inconsistency. 
 
Key Words: medication adherence, mobile phone app, pill image, electronic monitoring, 
REDCap, MyCap. 
 
 1. Introduction 
 
Medication non-adherence is a common and serious problem that reduces therapeutic efficacy 
and increases healthcare costs and contributes to deaths. In clinical trials, non-adherence may 
lead to erroneously accepting or rejecting claims of efficacy. Accurate measurement of 
adherence is, therefore, important, and although many methods have been used to assess 
adherence, all have drawbacks. Patients and research subjects may be reluctant to admit to non-
adherence and self-reporting data overestimate adherence by as much as 300% [4]. Treating 
physicians’ estimates of adherence are also poor. One study found that healthcare professionals 
overestimate adherence by 50% [5]. Traditional counts of dosage units, for example, capsules, do 
not provide information on when capsules are taken, or even if they were taken at all [6].  
 
2. Method 
 
2.1. Software 
 
Research Electronic Data Capture (REDCap) is a browser-based, metadata-driven software 
and workflow methodology for designing clinical and translational research databases.[1] It is 
widely used in the academic research community: the REDCap Consortium is a collaborative, 
international network of more than 2400 institutional partners in over 115 countries, with more 
than 590,000 total end-users employing the software for more than 450,000 ongoing research 
studies.[2] 
 
MyCap is a mobile phone application developed by staff at Vanderbilt University. MyCap is 
a iPhone® and Android application that can be downloaded from the Apple Store® and Google 
Play®. It leverages Apple's Research Kit® (ResearchStack on Android) and the device's built-
in sensors to collect participant information directly from study participants. MyCap leverages 
REDCap, ResearchKit, and ResearchStack to capture participant/patient reported 
outcomes via mobile devices. REDCap is used to define tasks/instruments/surveys to be 
completed by participants. MyCap translates REDCap task metadata into a structure 
compatible with ResearchKit and ResearchStack. When a project participant completes a task, 
MyCap converts the results into a format compatible with REDCap before synchronizing 
back to the REDCap project.[3] 
 
 
2.2. Study Setting and Participants 
 
The study administration took place in at TruMedicines Company (Sammamish, WA) and the 
University of Washington, (Seattle, WA) from October 2018 to September 2019. Study 
participants were randomly recruited from a lounge/dining area at the University of Washington 
Health Sciences facility. A total of 34 participants were recruited to participate in the study. Out 
of these, 26 (76.5%) participants were able to complete study questionnaire while 8 (23.5%) 
were not able.  (14 male, 12 female) volunteered to participate. Each participant were asked to 
take part in a 2 week trial of a MyCap mobile phone application created to track medications 
and health measures. Each participant was given a box of 14 harmless placebo medications 
(breath mints), individually packaged “pills” in pill packets. Participants were instructed to take 
1 pill per day (7 capsules per week). Participants took placebo medication over 2 weeks. 
Participants were told they would earn a $20 gift certificate at the end of the study period. This 
study was approved by the University of Washington Institutional Review Board (IRB) as a Non-
Significant Risk (NSR) study. 
 
Participants used their own android phones and were provided a labeled 
box of placebo medications with a Quick Response (QR) code to allow 
them to register into the study and input their health measure answers 
into the REDCap study database. The mobile phones were not 
modified and served as fully functional voice and text communication 
systems, as participants were able to make personal phone calls and 
send text messages to study administrators. Participants were given a 
$25 dollar gift card if they successfully completed the 2 weeks study 
period. 
 
Participants were instructed to photograph their placebo medication 
“dose” each day (Photo #1) and answer the accompanying health related 
questions. They were instructed to pull one pill packet from their pill 
box, remove the pill packet from the box and photograph the placebo 
pill before consuming the pill. Each image embedded a time stamp 
indicating when the medication was held by the study participant.  
          
 
3. Results 
 
Results in Table1 show that majority (73.1%) of the participants were aged between 18 and 34 
years old. Those who were aged between 35 and 54 years old comprised of 23.1% and only one 
participant was aged above 55 years. Results have indicated that more than half of the 
participants (53.9%) were males and only 46.2% were females. 
Findings have further indicated that 12 (52.2%) of the respondents always took their medications 
during the morning hours, 6 (26.1%) took their medication both in the morning and night while 
only 5(21.7%) always took their medication dose during the night hours.  
 The results have further indicated that the average stress level for the participants is 4.42 (2.23). 
The stress level was further categorized three levels; (1) none (zero stress level, (2)-between 1-4 
grouped as low stress level and (3) between 5-8 grouped as high stress level.  The table has 
shown that 15 (57.7%) of the participants were experiencing high stress level, 10 (38.5%) of the 
respondents were experiencing low/moderate stress level and only one participants was not 
stressed during the time of the study (was experiencing zero levels of stress). 
Table 1: Socio-demographic characteristics of the participants  
Characteristics  Frequency (N) Percent (%) 
Age      
18-34 19 73.1 
35-54 6 23.1 
55+ 1 3.9 
Gender 
 
Male  14 53.9 
Female  12 46.2 
Medication time  
  In morning 12 52.2 
Both morning &night  6 26.1 
At night  5 21.7 
 Stress, mean(SD) 4.42 2.23 
Stress level  
 None  1 3.9 
low 10 38.5 
high 15 57.7 
 
Fig1 shows the number of participants who used the recap repeat instrument and their corresponding 
average number of repeat instances. Participants used more than one instrument.  The results have 
revealed that all the participants who completed the questionnaire used the introduction survey instrument 
and it was averagely used once by each individual.  Out of 26 participants who were involved in the 
study, 21 (80.77) used the medication instrument and the mean time each individual used this instrument 
was 9 times. The findings have further revealed that 23 (88.5%) used the Daily task instrument and the 
average number of times each individual used this instrument was 9 times. Only one participant used the 
monthly questionnaire instrument. The results in fig 1 further indicated that 11(42.3%) used the app 
appropriateness tool and each individual used this instrument approximately once.   
Fig 1: Frequency and Number of participants per REDcap repeat instrument  
 
 
 
 
 
 
 
 
 
 
 
Table 2 shows the relationship between respondent`s choice of the recap read instrument and different 
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stress level. However, only age had a statistically significant relationship with choice of the monthly 
questionnaire as a REDcap read instrument. Only one individual aged above 55 years used monthly 
questionnaire as a REDcap read instrument.  
Table2: Relationship between recap read instrument and demographic characteristics  
Characteristic 
Medications  Daily tasks  Monthly questionnaire  App appropriateness  
Yes No Yes No Yes No Yes No 
Age  
 
  
 
      
 
  
18-34 16 (84.2) 03 (15.8) 17 (89.5) 02 (10.5) 0 (0.0) 19 (100.0) 07 (36.8) 12 (63.2) 
35-54 04 (66.47) 02 (33.3) 05 (83.3) 01 (16.7) 0 (0.0) 6 (100.0) 03  (50.0) 03 (50.0) 
55+ 01 (100.0) 0 (0.00) 1 (100.0) 0 (0.00) 1 (100.0)    0 (0.0) 01 (100.0)  00 (0.0) 
  P value =0.652 P value = 0.859 P value = 0.000** P value=0.419 
Gender 
 
  
 
      
 
  
Male  12 (85.7) 02 (14.3) 12 (85.7) 02 (14.3) 1 (7.1) 13 (92.9) 07 (50.0) 07 (50.0) 
Female 09 (75.0) 03 (25.0) 11  (91.7) 01 (8.3) 0 (0.0) 12 (100.0) 04 (33.3) 08 (66.7) 
  P value = 0.490 P value = 0.636 P value = 0.345 P value=0.391 
Medication time  
 
  
 
      
 
  
Morning  09 (81.8) 02 (18.2) 10 (90.9) 01(90.9) 0 (0.0) 1 (100.0) 1 (100.0) 0 (0.0) 
Morning & night  04 (66.7) 02 (33.3) 04 (66.7) 02 (33.3) 01 (10.0) 9 (90.0) 5 (50.0) 05 (50.0) 
At night  05 (100.0) 0 (0.00) 05 (100.0) 0 (0.0) 15 (100.0) 15 (100.0) 05 (33.3) 10 (66.7) 
  P value = 0.361 P value = 0.228 P value = 0.435 P value = 0.350 
Stress level  
 
  
 
      
 
  
None        1 (100.0) 0 (0.0) 1 (100.0) 0 (0.0) 01 (9.09) 10 (90.9) 06 (54.6) 05 (45.52) 
Low  7 (70.0) 3 (30.0) 10 (100.0) 0 (0.0) 0 (0.0) 6 (100.0) 02 (33.3) 04 (66.7) 
High 13 (86.7) 02 (13.3) 12 (80.0) 3 (20.0) 0 (0.0) 5 (100.0) 02 (40.0) 03 (60.0) 
  P value = 0.517 P value = 0.288 P value =0.592 P value=0.676 
 
The study further explored the different side effects that were experienced by the individuals when taking 
different kind of medicine. Table 3 shows the number of times of occurrence of each side effect. Majority 
of the individuals, 24 (92.3%) didn’t experience any side effects for instance nausea, vomiting, diarrhea 
and heart burn when taking TruMedicines. Findings form table 3 have indicated that only 1 (3.9%) 
experienced nausea as side effects. Also 1 (3.9%) experienced nausea as a side effect 6 times when taking 
TruMedicines. Only 2(7.7%) of the respondent experienced vomiting once when taking the medicine. 
Results have shown that only 1(3.9%) experienced diarrhea once when taking the TruMedicines while 1 
(3.9%) experienced diarrhea four times when taking medicine. Only 2 (7.7%) of the respondent who were 
taking the TruMedicines experienced heart burn as a side effect once. Findings have also shown that only 
1(3.9%) individuals experienced other side effects rather that those mentioned in the questionnaire.  
Table3:  Occurrence of Side Effects  
Side effects 
No of times, N (%) 
0 1 4 6 
Nausea 24 ( 92.3 ) 1 (3.9) 0 (0.0) 1 (3.9) 
Vomiting 24 ( 92.3 ) 2 (7.7) 0 (0.0) 0 (0.0) 
Diarrhea 24 ( 92.3 ) 1 (3.9) 1 (3.9) 0 (0.0) 
Heart burn 24 ( 92.3 ) 2 (7.7) 0 (0.0) 0 (0.0) 
Others  25 (96.2) 0 (0.0) 1 ( 3.9) 0 (0.0) 
 
The study also explored the daily tasks that individuals do on a day to day basis as shown in table 4. 
Results have indicated that on average, each individual spends 8 hours of sleep each night and spends 30 
minutes exercising their bodies every day. Also on average, each individual drinks 26 ounces of water 
daily and the mean stress level for each individual was 5 with a range of 1-8 
 
Table 4: Descriptive Statistics of Daily tasks  
Daily tasks  Observations Mean (SD) Max Min 
Daily sleep hours  24 7.6 (1.01) 10 6 
Daily exercise minutes  23 30.0 (20.8) 79 0 
Daily ounces of water  21 26.2 (18.7) 64 0 
Stress level 23 4.5 (1.9) 8 1 
 
Table 5 shows the association between different daily tasks and the socio demographic factors. Gender 
and time of taking medication were statistically significant with the number of minutes of daily exercise.  
Result show that on average, females spend more 18 minutes exercising daily than the males.  Also, those 
individuals who take their medication at night spend more hours exercising as compared to those who 
take their medication in the morning.  
Table 5: Relationship between daily tasks and demographic factors  
Characteristic 
Hours of daily 
sleep, mean 
(SD) 
Minutes of daily 
exercise, mean 
(SD) 
Ounces of daily 
water, mean 
(SD) 
Stress level, 
mean (SD) 
Age    
 
    
18-34 7.8 (1.1) 26.8 (20.9) 25.4 (19.4) 4.76 (1.98) 
35-54 7.2 (0.8) 42.8 (19.4) 28.5 (20.8) 3.6 (1.8) 
55+ 7.0 (0.0) 23.0 (0.0) 30 (0.0) 5.0 (0.0) 
  P value =0.454 P value = 0.856 P value = 0.944 P value=0.499 
Gender    
    
Male  7.7 (1.1) 20.8 (4.0) 24.7 (5.6) 4.8 (1.7) 
Female 7.6 (0.99) 38.6 (6.7) 27.6 (6.2) 4.3 (2.10 
  P value = 0.846 P value = 0.04** P value = 0.635 P value=0.493 
Medication time    
 
    
In the morning  7.7 (1.2) 22.2 (15.0) 19.5 (14.6) 4.2 (20.0) 
Morning & night  7.4 (0.6) 23.6 (7.3) 37.0  (20.4) 4.4 (1.8) 
At night  7.6 (0.6) 55.8 (17.8) 45.3 (16.7) 5.3 (2.6) 
  P value = 0.840 P value = 0.003** P value = 0.050 P value = 0.350 
 
 
Respondents also answered some questions about the app usability as shown in table 6. Results have 
shown that almost all, 09 (90.0%) found the app easy to use and majority 3 (75.0%) of these were males. 
More than half, 06 (60.0%) of the respondents responded that they would use the app every day if they 
were taking medication in the future. Majority of the respondents (80.0%) found direct pill scanning 
useful to them. Findings have further indicated that most of the respondents (80.0%) reported that the 
medication progress charts helped them to stay on track when taking the placebo pills. Also majority 09 
(90.0%) of the respondents felt like they were in control of their medication therapy.  
 
Table6: Usability of the App  
usability questions Overall, N (%) Male, N (%) Female, N (%) 
App easy 09 (90.0) 06 (100.0) 3 (75.0) 
App everyday 06 (60.0) 4 (66.7) 2 (50.0) 
App scanning pill 8 (80.0) 6 (100.0) 2 (50.0) 
App charts 8 (80.0) 5 (83.3) 3 (75.0) 
Feeling in control 9 (9.0) 6 (100.0) 3 (75.0) 
App medication  9 (90.0) 6 (100.0) 3 (75.0) 
 
Of the 26 participants, 14 (51%) were men and 12 (49%) were women. Participant’s age range 
was <18yrs (0.0%), 18-34yrs (19, 70.4%), 35-54 (7, 25.9%), 55+ (1, 3.7%). Participants owned a 
mobile phone and were familiar with modern mobile phone applications. Participants were able 
to use their phone to scan the study access QR code and install the application without 
assistance.  Overall adherence percentage of prescribed placebo medication tracked estimated by 
self-reported daily count was 92.9%. (Chart #1) 
 
 
Participants self-reported feeling in ‘control’ of their medication as shown by a (92.9% , Yes 
count in Chart #2. 
 
 
 
 
Participants self-reported a feedback of a daily historical chart of their medication progress 
helped them improve their medication adherence or as stated ‘stay on track’. As shown by a 85% 
self-reported yes count in Chart #3. 
 
 
                          
 
4.  Discussion 
 
It is important to highlight that the current mobile health app market is generally unregulated by 
any government or reporting agencies. In general, phone application ‘online stores’ provide 
guidelines about restricted content, privacy, and security of the data, and monetization of the 
apps; however, these guidelines are not a quality control assessment of the available apps. 
Recently, the US Food and Drug Administration (FDA) released a guidance document stating 
which type of mobile medical apps will be subject to their regulation [7]. However, at this stage, 
apps to promote medication adherence will not be within the FDA regulation oversight, as these 
apps are not intended to provide diagnosis or treatment recommendations.[8] 
 
“For short-term treatments several quite simple interventions increased adherence and improved 
patient outcomes, but the effects were inconsistent from study to study with less than half of 
studies showing benefits. Current methods of improving adherence for chronic health problems 
are mostly complex and not very effective, so that the full benefits of treatment cannot be 
realized. High priority should be given to fundamental and applied research concerning 
innovations to assist patients to follow medication prescriptions for long-term medical 
disorders”.[9] 
 
The ability of mobile telephones to save and transmit photographs as they are collected allows 
for more frequent assessment of adherence. Use of mobile phones for clinical purposes may be 
seen as an analog of industry’s successful development of other technology to monitor 
medication use and effects, for example, take-home devices for measurement of blood pressure, 
pulmonary function, glycemic index, and anticoagulant activity. In addition to adherence 
tracking, photographs with accurate timestamps of medication provide more accurate tracking by 
online database of at-home medication use on measurable, at-home self-reported physiological 
effects. Other capabilities of mobile phones invite investigation for clinical use; for example, 
image recognition of pill identify or type, tele medication video calls of at-home treatment and 
symptoms, text messaging for symptom severity tracking, and patient reminders.  Trials without 
incentives might show different adherence patterns. Incentives have been shown to increase 
adherence whether measured by self-report, pill count, or electronic monitoring [10].  
Mobile phones themselves might provide a convenient vehicle for incentives for desired 
behaviors, for example, credits to mobile phone billing or other micropayments, free downloads 
of phone applications, increased mobile phone time, or text messaging limits, etc. Study 
limitations include our small sample size, a larger trial would be better suited to detect 
meaningful differences and similarities between adherence measures. Finally, administration of a 
marker of adherence that can be detected in the urine [11] would permit a more precise estimate 
of the utility of this technique. For patients who already own camera-equipped mobile 
telephones, instructing them to e-mail photographs is an inexpensive and easily implemented 
method of measuring medication adherence. Innovative uses of mobile telephones offer 
researchers and clinicians new ways to improve clinical trials and practice. Pill photographs are a 
useful measure of adherence, allowing more accurate time measures and more frequent 
adherence assessment. Given the ubiquity of mobile telephone use, and the relative ease of this 
adherence measurement method, we believe it is a useful and cost-effective approach. However 
we feel the ‘manual’ nature of using the phone for taking a photograph of a pill has individual 
variability and an ‘automatic’ method is needed to reduce medication image inconsistency  
 
5. Conclusions   
 
Pill photographs are a useful measure of adherence, allowing more accurate time measures and 
more frequent adherence assessment. Given the ubiquity of mobile telephone use, and the 
relative ease of this adherence measurement method, we believe it is a useful and cost-effective 
approach. However we feel the ‘manual’ nature of using the phone for taking a photograph of a 
pill has individual variability and an automatic method is needed to reduce medication image 
inconsistency. 
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